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Abstract
Background: Daily monitoring of fetal and maternal conditions in complicated pregnancies leads to recurrent outpatient visits
or (prolonged) hospitalization. Alternatives for hospital admissions include home-based monitoring with home visits by professionals
or telemonitoring with self-measurements performed by pregnant women and uploaded for in-clinic assessment. For both
alternatives, cardiotocography and blood pressure measurement can be performed at home. It is unknown to what extent, for
which reasons, and for which pregnancy complications these strategies are used.
Objective: This study aims to assess the current practice and attitudes concerning home-based monitoring (with daily home
visits by professionals) and telemonitoring (using devices and the internet for daily self-recorded measurements) in high-risk
pregnancies requiring maternal and fetal monitoring in the Netherlands.
Methods: This nationwide cross-sectional study involved sending a web-based survey to the obstetrics departments of all 73
hospitals in the Netherlands to be answered by 1 representative dedicated to pregnancy monitoring per hospital. The primary
outcome was the provision of home-based monitoring or telemonitoring using cardiotocography between 1995 and 2018. The
survey further addressed perspectives regarding the use of home-based monitoring and telemonitoring, including (contra)indications,
advantages, and disadvantages for pregnant women and clinicians.
Results: The response rate for the provision of either home-based monitoring or telemonitoring was 100%. In 2018, 38% (28/73)
of centers in the Netherlands offered either home-based monitoring or telemonitoring or both to pregnant women with complications.
Home-based monitoring was offered in 26% (19/73) of the centers; telemonitoring, in 23% (17/73); and both in 11% (8/73).
Telemonitoring was first offered in 2009, increasing from 4% (3/73) of hospitals in 2014 to 23% (17/73) in 2018. Responses
were received from 78% (57/73) of the invited hospitals and analyzed. Of all 17 centers using telemonitoring, 59% (10/17) did
not investigate perinatal outcomes, safety, and patient satisfaction prior to implementation. Other (6/17, 35%) telemonitoring
centers are participating in an ongoing multicenter randomized clinical trial comparing patient safety, satisfaction, and costs of
telemonitoring with standard hospital admission. Home-based monitoring and telemonitoring are provided for a wide range of
complications, such as fetal growth restriction, pre-eclampsia, and preterm rupture of membranes. The respondents reported
advantages of monitoring from home, such as reduced stress and increased rest for patients, and reduction of admission and
possible reduction of costs. The stated barriers included lack of insurance reimbursement and possible technical issues.
Conclusions: Home-based monitoring is provided in 26% (19/73) and telemonitoring, in 23% (17/73) of hospitals in the
Netherlands to women with pregnancy complications. Altogether, 38% (28/73) of hospitals offer either home-based monitoring
or telemonitoring or both as an alternative to hospital admission. Future research is warranted to assess safety and reimbursement
issues before more widespread implementation of this practice.
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Introduction
Pregnancies with complications need close antenatal
surveillance. Although 7-10 antenatal consultations are
recommended in uncomplicated pregnancies, complications
result in recurrent outpatient visits or hospital admission [1].
These complications include fetal growth restriction,
pre-eclampsia, and preterm prelabor rupture of membranes
(prevalence of 3%-7%, 1%-3%, and 1%-5%, respectively) [2-4].
Daily monitoring with cardiotocography (CTG), blood pressure
measurements, and/or urine and blood analysis is recommended
in international guidelines to assess maternal and fetal conditions
in high-risk pregnancies [5-7]. Ultimately, hospitalization is
indicated in up to 11% of all pregnancies, usually extending to
delivery and the postpartum period [5-7]. Antenatal admissions
pose psychological stress to pregnant women because of
separation from family and home, lack of activity, and feelings
of uncertainty [8,9]. In addition, hospital admissions increase
health care costs and workload, especially in high-income
countries that are already experiencing difficulties as a result
of professional staff shortage [10].
Since 1990, obstetrics departments in the Netherlands have been
providing domiciliary care or “home-based monitoring” to
women with high-risk pregnancies. As an alternative to clinical
admission, home-based monitoring involves daily home visits
from hospital-employed midwives or nurses for pregnant women
with complications. Medical tests, including CTG, are performed
at home, and the results are discussed with a supervising
gynecologist (Figure 1A). Multiple randomized trials have
proved that home-based monitoring with home visits is feasible
and safe with regard to perinatal outcome [11-14]. Although
these trials demonstrated satisfactory outcomes for both mother
and child, the daily visits were also found to be time-consuming
and, therefore, expensive.
The use of digital health for remote monitoring in pregnancy
care is increasingly popular, as pregnant women are frequent
users of smartphones, the internet, and health apps [15].
Telemonitoring is a relatively new approach in high-risk
pregnancy and is recognized as an alternative to hospital
admission or home-based monitoring with prenatal home visits.
After training participants, daily measurements of blood pressure
and CTG are self-recorded by the patient at home and sent via
Bluetooth or WiFi to a secured digital platform. Using an
internet connection, the data are integrated in the electronic
patient file (Figure 1B). Patients are contacted by their clinician
on a daily basis to discuss the presence of symptoms, tests
results, and future management. Multiple telemonitoring
platforms for remote CTG have been evaluated in prospective
studies, and their feasibility, usability, accuracy of tracings, and
acceptability by patients and clinicians are proven [15].
In general, digital health has the potential to improve access to
care, disease monitoring, and patient satisfaction while reducing
health care costs due to a reduction in visits and admissions.
Currently, the clinical evidence for telemonitoring using CTG
in complicated pregnancies is too scarce to support hypotheses
regarding its effects on perinatal outcome, safety, patient
preference, and costs.
A number of hospitals in the Netherlands currently provide
either home-based monitoring or telemonitoring or both to
women with high-risk pregnancies. It is unknown to what extent,
for which reasons, and for which pregnancy complications these
strategies are used. This information is relevant for clinicians
planning to use a telemonitoring strategy in prenatal care. The
aim of this nationwide survey study is to determine the number
of hospitals in the Netherlands that provide home-based
monitoring or telemonitoring or both, and to identify the current
practice of out-of-hospital care in high-risk pregnancies.
Figure 1. Definition and illustration of (A) home-based monitoring and (B) telemonitoring in pregnancy.
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We conducted a nationwide cross-sectional study using a
web-based survey amongst obstetrics care professionals. All
hospitals with pregnancy and childbirth care departments in the
Netherlands (N=73) were invited to participate in our survey.
They were asked to appoint one of their obstetrics care
professionals dedicated to (remote) pregnancy monitoring as
the department representative to answer the questions on behalf
of the hospital. After receiving additional information about the
purpose of the study, access was provided to our web-based
survey. The survey link was sent via email in November 2018
and followed by a maximum of 3 email reminders.
Nonrespondents were contacted once more by phone to answer
the principal question “Does your center currently offer
home-based monitoring or telemonitoring in pregnancy?”
The survey was self-developed and based on expert knowledge
of home-based monitoring and telemonitoring in the
Netherlands. A professor of obstetrics, a perinatologist, a
hospital-based midwife, and 2 researchers, all with extensive
experience in home-based monitoring of high-risk pregnancies,
were involved in its development. It contained a maximum of
44 questions depending on whether home-based monitoring or
telemonitoring was offered. The open and multiple-choice
questions addressed 4 domains: (1) Basic demographics of the
respondent, (2) home-based monitoring, (3) telemonitoring, and
(4) advantages and disadvantages of home-based monitoring
and telemonitoring, as perceived by the respondent (see
Multimedia Appendix 1).
The survey sought information on the total number of births
per year in order to compare the hospitals with reference to size.
Regarding the provision of home-based monitoring or
telemonitoring, the starting year and, if applicable, year of
discontinuation were queried. We defined our study period from
1995 to 2018. Questions regarding indications, management
protocols, and (dis)advantages of the strategies were asked
bearing in mind the centers’ practice for the year 2018. The
introduction to our survey defined home-based monitoring as
“daily pregnancy monitoring with help of hospital personnel
traveling to the pregnant women’s homes.” Telemonitoring was
defined as “daily pregnancy monitoring with the help of devices
used by pregnant women at home in the absence of hospital
personnel” (Figure 1). Simple descriptive statistics were used
to describe the results. No ethical approval was required for this
study because actual patients were not involved. 
Results
Current Provision of Home-Based Monitoring and
Telemonitoring in High-Risk Pregnancy
In 2018, 73 hospitals in the Netherlands provided pregnancy
and childbirth care. The principle question, namely “Does your
center currently offer home-based monitoring or telemonitoring
in pregnancy?” was answered by all 73 invitees, resulting in a
response rate of 100%.
In 2018, 26% (19/73) hospitals offered home-based monitoring
with home visits by an obstetrics professional (nurse or midwife)
for women with high-risk pregnancies. Nationwide, 23% (17/73)
of hospitals offered telemonitoring in 2018 to women with
high-risk pregnancies (Table 1). Moreover, 11% (8/73) of
centers reported offering both home-based monitoring with
home visits and telemonitoring to their patients.
In obstetrics departments with ≤1000 births per year,
home-based monitoring and telemonitoring is limited to 0 and
1 centers, respectively. As for the different types of hospitals,
8 of 9 Dutch tertiary care hospitals with a neonatal intensive
care unit facility currently offer home-based monitoring or
telemonitoring or both for high-risk pregnancy management.
The geographic distribution of hospitals with home-based
monitoring and telemonitoring is displayed in Figure 2 for all
12 provinces of the Netherlands.
Table 1. Number of hospitals offering home-based monitoring and telemonitoring for high-risk pregnancies in 2018 in relation to the number of births
per hospital per year.
Telemonitoring (n=17), n (%)aHome-based monitoring (n=19), n (%)aNumber of hospitals (N=73), n (%)aNumber births per hospital per year
1 (7)0 (0)15 (21)0-1000
8 (23)9 (26)35 (48)1001-2000
6 (29)9 (43)21 (29)2001-3000
2 (100)1 (50)2 (2)>3000
aPercentages in these columns are based on the number of hospitals in each row.
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Figure 2. Geographic distribution of home-based monitoring and telemonitoring in 12 provinces of the Netherlands (N=73). HM: hospitals with
home-based monitoring/all hospitals in this province; TM: hospitals with telemonitoring/all hospitals in this province.
For the studied period of 1995-2018, the trend line in Figure 3
shows that home-based monitoring in pregnancy has been
offered since the mid-1990s. Most of these centers continued
offering daily home visits over a longer period of time, reaching
a peak in 2015. After the introduction of pregnancy
telemonitoring in 2009, the trend line for telemonitoring use
shows a steep increase from 2014 onwards, from 4% (3/73) of
centers in 2014 to 23% (17/73) in 2018. This increase in number
is accompanied by a slight drop in home-based monitoring
provision.
Figure 3. Trend graph of obstetrics departments offering home-based monitoring and telemonitoring for high-risk pregnancies in the Netherlands.
Survey Results
Respondents’ Characteristics
Of the total 73 invited hospitals, 57 participated in the web-based
survey (response rate 78%). Of these respondents, 45% (26/57)
worked in a teaching hospital, 39% (22/57) served in a
nonteaching hospital, and 16% (9/57) worked in an tertiary care
hospital with a neonatal intensive care unit. Moreover, 14%
(8/57) reported 0-1000 births per year, 51% (29/57) had
1001-2000 births per year, 32% (18/57) recorded 2001-3000
births per year, and 3% (2/57) reported over 3000 births per
year.
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Declining Trend of Home-Based Monitoring
The results showed that 11% (6/57) of centers offered
home-based monitoring in the years between 1995 and 2018
but stopped performing pregnancy monitoring with home visits.
The median number of years of home-based monitoring
provision was 7.5 years (range 2-18 years). Several reasons
were provided for the discontinuation, such as very few possible
candidates (3/6, 50%), problems with staff capacity (3/6, 50%),
financial capacity issues (2/6, 33%), and switching over to
telemonitoring without home visits (2/6, 33%).
Moreover, 42% (8/19) of hospitals with home-based monitoring
considered switching to telemonitoring, stating that the latter
provides higher patient satisfaction and does not require hospital
staff to visit patients at home. Interestingly, 16% (3/19) of
hospitals providing home-based monitoring did not change to
telemonitoring because they are satisfied with their current
home-based monitoring strategy. They stated that telemonitoring
allows neither daily direct clinical assessment of the patient by
a nurse/midwife nor the ability to monitor twin pregnancies.
Evaluation of Use
In 63% (12/19) of hospitals offering home-based monitoring,
implementation of such monitoring was not preceded by a
center-specific evaluation phase. However, home-based
monitoring in these centers started mainly after the publication
of the findings of 2 Dutch trials, which concluded positively
about its patient safety and effects on satisfaction of care [7,8].
As for telemonitoring, 35% (6/17) of centers are participating
in a multicenter randomized controlled trial comparing clinical
hospital admission with telemonitoring in pregnancies requiring
daily fetal monitoring. The aim of this trial is to compare patient
safety, user satisfaction, and cost-effectiveness; its protocol can
be found elsewhere [16]. The remaining 59% (10/17) of centers
reported they neither participated in nor started evaluation of
use of this novel strategy with daily self-measurements prior to
implementation in complicated pregnancies in their centers.
Indications and Management in Home-Based Pregnancy
Monitoring
Responding centers implementing either home-based monitoring
or telemonitoring reported similar lists of pregnancy
complications, which they considered eligible for daily
monitoring outside their hospital (Table 2). Both fetal growth
restriction and preterm rupture of membranes are considered
eligible for home-based monitoring as well as telemonitoring
in every center.
All (18/18, 100%) home-based monitoring centers reported that
at home, midwives or nurses measure patients’ blood pressure
levels and perform CTGs during their visits. Fetal condition
monitoring of both singleton and twin pregnancies using CTG
is possible in 83% (15/18) of centers. Additionally, urine
analysis (13/18, 72%), venous blood sampling (12/18, 67%),
and medication administration (4/18, 22%) can be performed
by professionals at home. This is in contrast to telemonitoring
centers, where only blood pressure monitoring and CTG are
performed by patients themselves at home.
Hospitals with either home-based monitoring or telemonitoring
also reported on the following patient-specific contraindications
for home-based monitoring: inability to follow instructions or
difficulty in understanding the system (26/28, 93%), long
home-to-hospital distance (25/28, 89%), existing antepartum
hemorrhage (20/28, 71%), and vulnerable home situation or
social issues experienced by the patient (14/28, 50%). Other
mentioned general contraindications were gestational age<25
weeks and preterm premature rupture of membranes without
engaged fetal head or breech. To ensure the safety of the patients
by minimizing travel time if complications occur, the
respondents clarified that patients must reside within a distance
of 30-35 km from their hospital.
Table 2. Indications for home-based monitoring (n=19) and telemonitoring (n=17) in high-risk pregnancies.
Telemonitoring centers, n (%)Home-based monitoring centers, n (%)Indications
17 (100)19 (100)Fetal growth restriction
17 (100)19 (100)Preterm premature rupture of membranes
2 (12)5 (26)Prolonged prelabor rupture of membranes at term
4 (24)10 (53)Isolated oligohydramnios
15 (88)15 (79)Reduced fetal movement
3 (18)9 (47)Fetal anomalies requiring fetal monitoring
15 (88)16 (84)(Adverse) Obstetrics patient historya
10 (59)15 (79)Hypertensive pregnancy disorders
5 (29)14 (74)Cholestasis of pregnancy
4 (24)11 (58)Other maternal comorbiditiesb
5 (29)11 (58)Social or psychological distress
aFor instance, intrauterine fetal death in a previous pregnancy.
bFor instance, (gestational) diabetes mellitus, kidney disease, and cardiac disease requiring maternal monitoring.
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Reported Advantages and Disadvantages of Home-Based
Monitoring and Telemonitoring
The most frequently addressed advantages of home-based
monitoring and telemonitoring for the patients, as perceived by
the respondents, include more patient comfort and less emotional
burden of hospitalization for the patient as they continue with
daily (family) life and activities as much as possible. Other
frequently mentioned advantages are summarized in Table 3.
Possible disadvantages of home-monitoring and telemonitoring
for the patient include the possibility of a delay in providing
help in case of an emergency or acute problem, because the
patient is not physically present in the hospital. Technical and
security issues regarding the devices are also mentioned (Table
3).
The respondents reported a number of perceived benefits of
home-based monitoring and telemonitoring for the health care
provider, the most important being the reduction in the number
of admissions, which in turn may lower health care costs (45/57,
79%) and reduce the burden on hospital personnel (26/57, 46%).
The most common disadvantages of home-based monitoring
and telemonitoring for the clinicians are costs and
reimbursement (38/57, 67%) and inability to conduct direct
patient assessments (18/57, 31%). For home-based monitoring
specifically, the most serious disadvantage was lack of sufficient
obstetrics personnel to make home visits (22/57, 39%).
Table 3. Advantages and disadvantages of home-based monitoring and telemonitoring for patients according to the respondents (n=57).
ValuesAdvantages or disadvantages
Advantages, n (%)
40 (70)Improved patient comfort
35 (61)Reduced (emotional) burden of admission
25 (44)Reduced stress/more rest
21 (37)Better patient autonomy
8 (14)Higher patient satisfaction
7 (12)Higher patient safety
2 (4)Reduced over-medicalization during pregnancy
Disadvantages, n (%)
38 (67)Possible delay in providing help during emergencies or acute problems
18 (31)No direct communication with the consulting gynecologist
13 (23)Patients’ inability to conduct CTGa at home
17 (30)Technical issues
12 (21)Inability to follow instructions
aCTG: cardiotocography.
Number of High-Risk Pregnant Women Managed From
Home
All (19/19, 100%) of home-based monitoring centers reported
monitoring a minimum of 745 to a maximum of 1140 patients
with a singleton pregnancy via home visits in 2018.
All of the telemonitoring centers (17/17, 100%) reported
monitoring a minimum of 400 to a maximum of 725 patients




Our survey results show the current practice in the Netherlands
regarding the use of home-based monitoring and telemonitoring
in high-risk pregnancies. In 1995, pregnancy monitoring with
daily home visits was available in only a few obstetrics
hospitals; currently, it is used by 26% (19/73) of all hospitals
in the Netherlands. The last 5 years have witnessed a steep
increase in the provision of telemonitoring; as of 2018, it was
used in 23% (17/73) of obstetrics departments. Furthermore,
almost half (8/19, 42%) of the hospitals with home-based
monitoring considered switching to telemonitoring using
self-measurement of fetal and maternal parameters. For the
telemonitoring centers, 59% (10/17) did not evaluate the use of
this digital health strategy with daily self-measurements prior
to implementation in their centers. Moreover, 35% (6/17) of
centers are currently participating in an ongoing trial to compare
traditional hospital admission and telemonitoring with regard
to patient safety, satisfaction, and costs.
In 2018, 1145-1865 pregnant women were monitored from
home with home visits or telemonitoring after diagnosis of 1
or more complications.
Strengths and Limitations
Our study involved a nationwide survey with a high response
rate and included both secondary and tertiary referral centers,
teaching and nonteaching centers, and a wide size range of units
according to annual birth numbers. The responses to the survey
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depended on the voluntary participation of the invited hospitals,
which could have led to selection bias. Furthermore, the
collected data were self-reported and hence subjective. Some
of the results on the impact of remote monitoring were based
on estimations by the respondents, which may limit the validity
of the conclusions. Evaluations of the characteristics of pregnant
women, relevant clinical outcomes (including safety), and user
experiences are critical for future health care improvements
using mobile health monitoring. However, this study was not
devised to evaluate these outcomes, which might be considered
a limitation.
Interpretation
The level of application of digital health in prenatal care is
evident, with pregnancy telemonitoring being one of the most
promising additions to new care models [9,15,17]. The
respondents of our survey identified important (perceived)
advantages of telemonitoring: improved patient-friendly care
in response to their needs, increased patient satisfaction and
autonomy, and reduced over-medicalization. These results are
in line with those of previous research on patient experiences
with digital health [15,18,19]. Furthermore, obstetrics care
professionals underscore the importance of digital health in
pregnancy care. For instance, a survey study conducted in
Belgium concluded that 80% (28/35) of midwives and 67%
(6/9) of obstetricians who used remote blood pressure
monitoring in pregnancy perceived digital technologies to be
an important component of prenatal monitoring [20]. Moreover,
a survey amongst 89 German physicians concluded that nearly
70% considered apps for pregnancy monitoring reasonable [21].
Other reported advantages in favor of telemonitoring are the
reductions in the number of admissions and the burden on
hospital personnel [18,19]. Staff shortages are also driving a
shift from hospital- to home-based care.
In the Netherlands, approximately 170,000 children are delivered
per year from both uncomplicated and complicated pregnancies.
We estimated earlier that 11% of pregnant women need antenatal
hospital admission because of complications, which equals to
18,700 women yearly [2-4]. Using our respondents’ results, we
calculated that 1145-1865 pregnant women were monitored
from home in 2018. This number indicates that roughly 6%-10%
of antenatal hospital admissions were replaced by home-based
monitoring or telemonitoring in 2018. Although exact numbers
on the length of hospitalization during high-risk pregnancies
are lacking, we can use these values to estimate the possible
impact of home-based and telemonitoring on admissions during
pregnancy. If home-based monitoring or telemonitoring services
in pregnancy were to replace 5 days or nights of hospitalization
per pregnant woman, the number of hospital admission days
would reduce by 5,725-9,325 annually.
Studies on telemonitoring implementation using patient-recorded
daily CTG are limited. Despite the inadequate knowledge of
the effects of pregnancy telemonitoring on perinatal outcomes,
patient experiences, and cost-effectiveness, this study shows
that telemonitoring is becoming increasingly popular in the
Netherlands. Although not mentioned by our respondents, legal
concerns such as third party control and use of data limit the
widespread use of digital health interventions. In the
Netherlands, external companies providing devices, software,
and storage of patient data for telemonitoring must provide
certain data security assurances. Evidence from clinical trials
and health technology assessments will help to better estimate
the exact budgetary impact from several different (ie, societal,
insurance, and hospital) perspectives. The costs involved in the
development, use, and maintenance of the devices, as well as
the manner in which they are imbedded in current practice,
should also be calculated to assess the added value of pregnancy
telemonitoring. Our survey respondents reported challenges
with reimbursement, since no insurance coverage for pregnancy
telemonitoring exists in the Netherlands. Financial issues were
another primary reason mentioned by our respondents
(especially the smaller obstetrics units) to not offer either
home-based monitoring or telemonitoring. It is well known that
insurance companies only cover well-researched digital health
interventions in accordance with their economic evaluations
[22,23]. To compare daily telemonitoring at home with
traditional hospital care for complicated pregnancies, a
multicenter randomized controlled trial, HOTEL (HOspital
admission versus TELemonitoring in high risk pregnancy), is
currently recruiting participants in 6 Dutch hospitals [16]. This
trial aims to compare both strategies with regard to perinatal
outcomes, patient satisfaction, and cost-effectiveness.
Recommendations for Research and Practice
Our survey study provides information about the current practice
and trends in the Netherlands regarding home-based monitoring
and telemonitoring in perinatal care. More detailed information
on the barriers and facilitators, from both the patients’and health
care providers’ viewpoints, may help develop other innovative
strategies in perinatal care. However, evidence on the medical
outcomes and patient safety with telemonitoring is still lacking,
and more information is required before implementing such
innovations in the target population. We must expand our
knowledge of these forms of care in order to continue moving
forward with digital health innovations. Consensus on the
implementation and research agenda can pave the road to the
widespread use of digital health services. Additional trials and
stakeholders’ views of digital health care are needed to develop
insurance reimbursement systems for such remote monitoring
innovations in pregnancy.
Conclusion
In 2018, 26% (19/73) of hospitals in the Netherlands offered
home-based monitoring and 23% (17/73) offered telemonitoring
to their patients with pregnancy complications. These
increasingly popular forms of home-based care allow an
increasing number of pregnant women in need of daily
monitoring to stay at home and avoid hospital admission.
Additionally, the survey respondents shed light on multiple
possible advantages and disadvantages of home-based
monitoring and telemonitoring in pregnancy. These results can
contribute to future evaluations of digital innovations in
pregnancy care, as further research on their safety, experience,
and cost-effectiveness is warranted before more widespread
implementation.
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